Intrinsic value of Intellia Therapeutics, Inc. (NTLA)
Live fair value data for Intellia Therapeutics, Inc. (NTLA) is currently unavailable. Please check again shortly.
Current Price: $283.00
Valuation: Overvalued
Confidence: 4.0/10
Visual Bar
This intrinsic value is calculated using 5 different models based on projected revenue growth, profit margins, and a standard discount rate.
Is Intellia Therapeutics, Inc. (NTLA) undervalued or overvalued?
Based on the current model output, Intellia Therapeutics, Inc. appears to be overvalued with a downside of 4.00%.
Fair value vs market price — Intellia Therapeutics, Inc. (NTLA)
Unlock premium access to view the live fair value comparison against current market price for NTLA.
Frequently Asked Questions - NTLA
How is NTLA intrinsic value estimated?
We combine revenue growth, discount rate, and terminal growth assumptions to estimate a fair value range for NTLA.
Is NTLA undervalued or overvalued right now?
NTLA is currently shown as overvalued based on the difference between market price and intrinsic value.
How should I use the confidence score?
The confidence score (0 to 10) indicates model certainty from available inputs. Higher values suggest stronger model consistency, not a guarantee of returns.
Related companies — intrinsic value
Peers for NTLA: open their intrinsic value pages.